INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

August 11, 2022

Period of Report

August 8, 2022

Accession Number

0001062993-22-017743